Keywords: Astellas, Neglected tropical diseases, Drug discovery, DNDi

Astellas enters neglected tropical diseases drug discovery scene in partnership with DNDi

Article | 14 June 2012

Print This

As a first critical step of its new strategy to enter into the field of neglected tropical diseases (NTD) drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in